Cargando…

HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK

Cervical cancer is the fourth most common malignancy in females worldwide, and a leading cause of death in the United Kingdom (UK). The human papillomavirus (HPV) is the strongest risk factor for developing cervical intraepithelial neoplasia and cancer. Across the UK, the national HPV immunisation p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Sunyoung, Ismail, Ayden, Pappas-Gogos, George, Boussios, Stergios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960303/ https://www.ncbi.nlm.nih.gov/pubmed/36839570 http://dx.doi.org/10.3390/pathogens12020298

Ejemplares similares

Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine
por: Samuel, Younan, et al.
Publicado: (2023)

Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
por: Ghose, Aruni, et al.
Publicado: (2021)

Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
por: Ioannidou, Evangelia, et al.
Publicado: (2021)

State-of-the-Art Molecular Oncology in UK
por: Sandoughdaran, Saleh, et al.
Publicado: (2023)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Unraveling the Wide Spectrum of Melanoma Biomarkers
por: Revythis, Antonios, et al.
Publicado: (2021)

Does the HPV vaccination programme have implications for cervical screening programmes in the UK?()
por: Beer, Helen, et al.
Publicado: (2014)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
por: Boussios, Stergios, et al.
Publicado: (2020)

Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Uptake of cervical screening.
por: Twaddle, S., et al.
Publicado: (1993)

Uptake of cervical screening.
por: Lamont, D. W., et al.
Publicado: (1993)

Proposal for cervical cancer screening in the era of HPV vaccination
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

Cervical Cancer Screening with HPV Testing: Updates on the Recommendation
por: Carvalho, Carla Fabrine, et al.
Publicado: (2022)

Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Urine HPV in the Context of Genital and Cervical Cancer Screening—An Update of Current Literature
por: Daponte, Alexandros, et al.
Publicado: (2021)

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2023)

Ovarian cancer: state of the art and perspectives of clinical research
por: Boussios, Stergios, et al.
Publicado: (2020)

HPV-Based Self-Sampling in Cervical Cancer Screening: An Updated Review of the Current Evidence in the Literature
por: Daponte, Nikoletta, et al.
Publicado: (2023)

Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art
por: Boussios, Stergios, et al.
Publicado: (2023)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data
por: Palmer, T J, et al.
Publicado: (2016)

Knowledge on cervical cancer and perceived barriers to the uptake of HPV vaccination among health professionals
por: Chellapandian, Poongodi, et al.
Publicado: (2021)

Cervical cancer screening by visual inspection and HPV testing in Eswatini
por: Ginindza, Themba G., et al.
Publicado: (2022)

Prevention of Cervical Cancer through HPV Vaccination and Screening in Maldives
por: Mullapally, Sujith Kumar, et al.
Publicado: (2023)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
por: Zeferino, Luiz Carlos, et al.
Publicado: (2018)

Cervical Cancer Screening Service Utilisation in UK
por: Labeit, Alexander, et al.
Publicado: (2013)

HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis
por: Mekuria, Selamawit F., et al.
Publicado: (2023)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

Epidemiology of HPV Infection and HPV-Related Cancers in Kazakhstan: a Review
por: Aimagambetova, Gulzhanat, et al.
Publicado: (2018)

HPV self-sampling for cervical cancer screening: a systematic review of values and preferences
por: Nishimura, Holly, et al.
Publicado: (2021)

Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico
por: Muñoz-Bello, J. Omar, et al.
Publicado: (2022)

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
por: Lagos, Marcela, et al.
Publicado: (2015)

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
por: Chrysostomou, Andreas C., et al.
Publicado: (2018)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
por: Wei, Baojun, et al.
Publicado: (2020)

Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
por: Arbyn, Marc, et al.
Publicado: (2022)

Drivers of cervical cancer screening uptake in Ibadan, Nigeria
por: Ilevbare, Oluwatosin E., et al.
Publicado: (2020)

An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
por: Saxby, Helen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_41064kdee7hldc6283loathkhl